Answers are grounded in this paper and cite their sources.
Evaluates antimicrobial and cytotoxic effects of platinum complexes in various models, indicating potential applications.
High Resolution Image Download MS PowerPoint Slide Four platinum(II) rollover cyclometalated complexes derived from 2,2’-bipyridine N -oxide (bpy NO ), [Pt(bpy NO -H)(DMSO)Me] ( 1a ), [Pt(bpy NO -H)(PPh 3 )Me] ( 2a ), [Pt(bpy NO -H)(DMSO)Cl] ( 3a ), and [Pt(bpy NO -H)(PPh 3 )Cl] ( 4a ), were synthesized, characterized, and evaluated for their antimicrobial and cytotoxic activities. The electron-poor nature of bpy NO enables rollover C–H bond activation at room temperature. NMR and X-ray analysis ( 4a ) revealed distinctive features, including an intramolecular interaction between the H 3′ hydrogen and the N-oxide oxygen. A correlation between the direct 195 Pt– 31 P coupling constant and the donating properties of cyclometalated ligands has been found, allowing a useful scale of donor properties. A preliminary screening of antimicrobial activity against E. coli, K. pneumoniae, S. aureus multidrug resistant (MDR), S. pyogenes, P. aeruginosa, and C. albicans demonstrated selective activity. Complex 3a showed the most promising results against E. coli and multidrug-resistant S. aureus . Significantly, the complexes also exhibited biofilm inhibitory behavior; notably, complex 1a showed activity against K. pneumoniae . Additionally, preliminary cytotoxicity tests on human tumor (HT29) cells and normal (CCD 841 CoN) cells were performed. Among the investigated compounds, 1a, 2a, and 3a exhibited a significant reduction in tumor cell viability, whereas complex 4a displayed moderate activity. These results establish 2,2’-bipyridine N -oxide as a promising ligand scaffold for developing platinum complexes.
No takes yet. Share an insight, caveat, or question.
Zucca et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: